Showing results (11-20 of 50) with videos related to
Sort By:
Pageof 5
Nature Communications|October 28, 2022
Chemical space docking enables large-scale structure-based virtual screening to discover ROCK1 kinase inhibitorsPaul Beroza, James J Crawford, Oleg Ganichkin, et al.Journal of Molecular Biology|May 21, 2018
Structure-Guided Combinatorial Engineering Facilitates Affinity and Specificity Optimization of Anti-CD81 AntibodiesBryce Nelson, Jarrett Adams, Andreas Kuglstatter, et al.Nature|March 25, 2015
MAP4K4 regulates integrin-FERM binding to control endothelial cell motilityPhilip Vitorino, Stacey Yeung, Ailey Crow, et al.Structure (London, England : 1993)|February 21, 2025
Discovery and characterization of potent macrocycle inhibitors of ubiquitin-specific protease-7Rafael Miranda, Francesca Anson, Shannon T Smith, et al.ACS Medicinal Chemistry Letters|September 19, 2019
Structure Based Design of Potent Selective Inhibitors of Protein Kinase D1 (PKD1)Jianwen A Feng, Patrick Lee, Moulay Hicham Alaoui, et al.Journal of Medicinal Chemistry|July 3, 2019
Discovery of Clinical Candidate (1<i>R</i>,4<i>r</i>)-4-((<i>R</i>)-2-((<i>S</i>)-6-Fluoro-5<i>H</i>-imidazo[5,1-<i>a</i>]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1Sanjeev Kumar, Jesse P Waldo, Firoz A Jaipuri, et al.Immunity|May 2, 2024
N4BP1 coordinates ubiquitin-dependent crosstalk within the IκB kinase family to limit Toll-like receptor signaling and inflammationAlexander D Gitlin, Allie Maltzman, Yuzuka Kanno, et al.Computational and Structural Biotechnology Journal|September 23, 2022
Antibody interfaces revealed through structural miningYizhou Yin, Matthew G Romei, Kannan Sankar, et al.Journal of Medicinal Chemistry|July 9, 2019
Design and Evaluation of Highly Selective Human Immunoproteasome Inhibitors Reveal a Compensatory Process That Preserves Immune Cell ViabilityEna Ladi, Christine Everett, Craig E Stivala, et al.The Journal of Biological Chemistry|February 28, 2009
Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virusJulie Qi Hang, Yanli Yang, Seth F Harris, et al.Pageof 5